Drug Target Review

NOVEMBER 1, 2023

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. Acta Cryst. Acta Cryst. 2013) 56, 2059-2073.

Fragment Screening

Sygnature Discovery

JANUARY 17, 2023

Sygnature Discovery (“Sygnature”) is delighted to announce the acquisition of SB Drug Discovery, a world leading provider of ion channel and receptor drug discovery research delivering cell line generation and compound screening solutions in neuroscience and other therapeutic indications.

Compound Screening

sptlabtech

APRIL 23, 2025

Its unique nanoliter liquid handling enables researchers to perform traditional experiments at a fraction of the volume, significantly increasing throughput while maintaining precision. These capabilities make it an invaluable tool for applications ranging from compound screening and medicinal chemistry to molecular and structural biology.

Drugs